CDMO
mRNA

ST PHARM's mRNA CDMO Core Strength

The Limitless Future of xRNA Therapeutics
Established IVT-based mRNA-LNP CDMO platform
  • 1mRNA Platform (5’ capping & LNP)
  • 2GMP Production Site (Banwol Campus)

ST PHARM's mRNA Core technology

Core technology for mRNA vaccines & therapeutics
  • 15’ capping (SMARTCAP®)
  • 2LNP Platform

SMARTCAP®

Strong IP position of ST PHARM's SMARTCAP®
using novel capping analogues.
SMARTCAP

mRNA

UTR

Coding Sequence

UTR

Capping
( SMARTCAP® )

ST PHARM's LNP Platform

ST PHARM is running 3 different LNP Platform strategies
  • 1In-licensing LNP
  • 2ST PHARM LNP (STLNP)
  • 3Next generation LNP (SMARTLNP)
SMARTLNP

mRNA-LNP

  • Helper lipidHelper lipid
  • lonizable lipidlonizable lipid
  • CholesterolCholesterol
  • Helper lipidLipid-anchored PEG
  • mRNAmRNA
SMARTCAP®
  • Cost-effective
  • Novel capping analogues
  • Various differrent types
SMARTCAP® Library
  • Customized capping choice
  • Apply in various targets
  • Identify the best capping
    (high capping efficiency)
STLNP
  • Platform for CDMO
  • Own patented
  • Advanced delivery system

ST Pharm's mRNA CDMO Service

ST PHARM's IVT-based mRNA-LNP CDMO Platform
New 5’ Capping Analogue
  • Novel ST PHARM's own cap analogues, SmartCap®
  • Capping library screening to select the most suitable capping analogue
IVT mRNA Synthesis
  • Ample know-hows in mRNA optimazation in IVT-based mRNA synthesis & codon optimization
Drug Delivery System (LNP)
  • Lipid-Nanoparticle (LNP) based mRNA delivery platforms with diverse collaborations with champions in the field
Purification
  • Leveraging in-house ample experience on oligonucleotide purification method using UF and HPLC
  • One-pot purification system
GMP Manufacturing
  • Strong track record of nucleotide/ oligonucleotide GMP manufacturer
  • All steps controlled under GMP conditions
CMC & Regulatory
  • Analytical and biophysical characterization & analytical method development
  • Regulatory SOP & guideline preparation

Capacity (Banwol Campus)

ST PHARM is highly dedicated to innovative, continuous improvement
and expanding mRNA facility
mRNA Plant
Capacity
Site
Note
Stage 1. (Aug. 2020)
R&D and small scale
(milligram/month)
mRNA Plant (1F)
Non-GMP
Stage 2. (May. 2021)
Mid-scale
(multi-gram/month)
mRNA Plant (1F & 4F)
GMP
Stage 3. (Planned)
Large-scale
(1.0kg/annum)
mRNA Plant (3F & 5F)
GMP
Banwol Campus
Banwol Campus

mRNA Plant